首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
Neue Enduracidinderivate und Verfahren zu ihrer Herstellung
摘要
申请公布号
DE1809875(A1)
申请公布日期
1969.07.03
申请号
DE19681809875
申请日期
1968.11.20
申请人
TAKEDA CHEMICAL INDUSTRIES LTD.
发明人
MIYAKE,AKIRA;UEYANAGI,JISABURO;IWASAKI,HIDESUKE;HORII,SATOSHI;NAITO,KENZO
分类号
C07K1/00
主分类号
C07K1/00
代理机构
代理人
主权项
地址
您可能感兴趣的专利
PHTHALOCYANINE PROBES AND USES THEREOF
Polyvalent Fusion Protein Vaccine Against Influenza
MILK-DERIVED BASIC PROTEIN FRACTION AS SKIN SENSITIVITY IMPROVING AGENT
PROTEIN THERAPY FOR TREATMENT OF RETINAL DISEASES
SOLID COMPOSITION
SYNERGISTIC PHARMACEUTICAL COMPOSITION FOR GASTROINESTINAL DISORDERS
ONCOLYTIC ADENOVIRUS COMPOSITIONS
GENETIC TEST FOR LIVER COPPER ACCUMULATION IN DOGS AND LOW COPPER PET DIET
Microporous Zirconium Silicate for the Treatment of Hyperkalemia
ACTIVATION OF iNKT CELLS
METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING INTESTINAL INJURY AND DISEASES RELATED TO TIGHT JUNCTION DYSFUNCTION
2-(R2-THIO)-10-[3-(4-R1-PIPERAZIN-1-YL)PROPYL]-10H-PHENOTHIAZINES FOR TREATING A B-AMYLOIDOPATHY OR AN A-SYNUCLEOPATHY, AND METHOD FOR THE DIAGNOSIS OR PREDIAGNOSIS THEREOF
TETRA-SUBSTITUTED NDGA DERIVATIVES VIA ETHER BONDS AND CARBAMATE BONDS AND THEIR SYNTHESIS AND PHARMACEUTICAL USE
SUBSTITUTED QUINOXALINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR4
COMPOSITIONS AND METHODS FOR INDUCING CONFORMATIONAL CHANGES IN CEREBLON AND OTHER E3 UBIQUITIN LIGASES
R-7-(3-AMINOMETHYL-4-METHOXYIMINO-3-METHYL-PYRROLIDIN-1-YL)-1-CYCLOPROPYL-6-FLUORO-4-OXO-1,4-DIHYDRO-[1,8]NAPHTHYRIDINE-3-CARBOXYLIC ACID AND L-ASPARTIC ACID SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR ANTIMICROBIAL
Composition and Method for Treating Tinnitus
THERAPEUTIC APPROACHES FOR TREATING EPILEPSY AND RELATED DISORDERS THROUGH REDUCTION OF EPILEPTOGENESIS
Nanoparticles for Controlled Release of Anti-Biofilm Agents and Methods of Use
THERMORESPONSIVE HYDROGEL CONTAINING POLYMER MICROPARTICLES FOR NONINVASIVE OCULAR DRUG DELIVERY
